Cardiovascular Disease in Multimorbidity – What’s Critical? (Recorded webinar)
Duration: 1 hour
Recognising and treating familial hypercholesterolaemia in a patient with comorbidities is critical. This 1-hour case-based on-demand webinar covers newer medications and their importance in treating and managing these patients for improved outcomes.
Learning objectives: Upon completing this course, you will be able to:
- Recall strategies to holistically manage patients with multimorbidity by considering their physical conditions along with their mental and social circumstances
- Recognise the benefits of improved communication and coordination with the multidisciplinary team in managing patients with multimorbidity
- List factors to consider for appropriate prescribing and deprescribing drugs for patients with multimorbidity
- Plan an improved strategy on structuring a consultation with patients with multimorbidity
Independent Medical Education
This program is supported through an independent grant from Amgen with other supporters still to be confirmed. Supporters are not involved in the development of content, selection or discussions with the faculty.
Professor Mieke van Driel is Emeritus Professor of General Practice, Faculty of Medicine, The University of Queensland. Mieke served as Head of the General Practice department from 2011 until she retired from her academic roles in 2021. Her research focuses on generating, synthesising and implementing evidence that is relevant to GPs in clinical practice. She continues to be involved in research and in mentoring junior researchers, but now has more time for clinical work as a General Practitioner in Aboriginal and Torres Strait Islander health.
Dr Chee L Khoo has been working as a solo GP in Ingleburn, NSW since 1990. He serves as the Education Chair at the Diabetes, Obesity and Metabolism Translational Research Unit (DOMTRU) at Southwest Sydney. He is also a member of the RACGP’s Specific Interest Groups in Diabetes and Obesity Management, and a Senior Lecturer in Medicine at WSU. Additionally, he is the editor in chief at GPVoice.com.au. Dr. Khoo is a member of the steering committee of the National Hyperglycaemia in Pregnancy Clinical Quality Program and a member of the GP advisory board of TID National Screening Program.
- Royal Australian College of General Practitioners:2 CPD points
- Reviewing performance (RP): 1 hour
For completing the pre- and post-activities - Educational activities (EA): 1 hour
For attending the 1- hour webinar - Activity no. 498418
- Reviewing performance (RP): 1 hour
- Australian College of Rural and Remote Medicine:
- Reviewing performance (RP): 1 hour
For completing the pre- and post-activities - Educational activities (EA): 1 hour
For attending the 1- hour webinar - Activity ID. 30231
- Reviewing performance (RP): 1 hour
Dr Khoo has served on advisory boards, received remuneration or travel support from Novo Nordisk, Eli Lilly, Sanofi and AstraZeneca.
Professor Mieke van Driel has no conflicts of interest.
